Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3820138

COc1cccc(-c2nnc(CN)o2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.54
KDM4E B2RXH2 5/20 0.54
HPGD P15428 4/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
KMT2A Q03164 3/20 0.53
NOTUM Q6P988 1/20 0.50
MAPT P10636 3/20 0.49
IKBKB O14920 1/20 0.49
PTK2 Q05397 1/20 0.48
TSHR P16473 2/20 0.47
GAA P10253 1/20 0.47
POLB P06746 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 2/20 0.47
TP53 P04637 3/20 0.47
MEN1 O00255 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3825063 0.88 KDM4E (0.67) SMN1; SMN2KDM4EHPGDNPC1RAB9A
Trifluoroacetic Acid SCHEMBL3827097 0.85 NOTUM (0.54) SMN1; SMN2KDM4EHPGDNPC1RAB9A
SCHEMBL3825288 0.84 NOTUM (0.49) SMN1; SMN2KDM4EHPGDNPC1RAB9A
Trifluoroacetic Acid SCHEMBL3825286 0.83 NOTUM (0.55) SMN1; SMN2KDM4EHPGDNPC1RAB9A
Trifluoroacetic Acid SCHEMBL3827046 0.83 NOTUM (0.55) NPC1RAB9AKMT2ANOTUMMAPT
Trifluoroacetic Acid SCHEMBL3822942 0.82 NOTUM (0.54) SMN1; SMN2NPC1RAB9ANOTUMMAPT
Trifluoroacetic Acid SCHEMBL3634061 0.80 KDM4E (0.58) SMN1; SMN2KDM4EHPGDNPC1RAB9A
Trifluoroacetic Acid SCHEMBL3822807 0.77 KMT2A (0.49) SMN1; SMN2HPGDNPC1RAB9AKMT2A
SCHEMBL17001624 0.76 KDM4E (0.64) SMN1; SMN2KDM4EHPGDNPC1RAB9A
Trifluoroacetic Acid SCHEMBL15573592 0.75 LRRK2 (0.59) SMN1; SMN2KDM4EHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 SMN1; SMN2 4002/4885KDM4E 1955/4885HPGD 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.